Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions
The present invention relates to the use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions having anti-atherosclerotic and anti-ischemic effects, and to the use thereof in methods for preventing and treating the atherosclerotic and ischemic (e.g. cardiac) diseases. The invention also relates to screening methods by which biglycan or enhancers of biglycan activity can be identified.
Potential investors and/or co-development partners, please contact us for further details at businessdevelopment@pharmahungary.com.
If you are interested in our project as an investor or co-development partner, please contact us for further details at businessdevelopment@pharmahungary.com.
Several miRNA compounds for cytoprotection in ischemic diseases, method of identification for cytoprotective miRNA targets, termed „protectomiRs”.
If you are interested in our project as an investor or co-development partner, please contact us for further details at businessdevelopment@pharmahungary.com.